The mission of NovaMedica is to create comprehensive therapy solutions for patients and their families to ensure the best result with the help of innovative and efficient medical technologies. The company offers patients new pharmaceutical drugs, technologies and other innovative products and services that have successfully proven themselves in various other countries but have not been available in Russia or the CIS before. Our solutions are intended for medical assistance at all stages, from diagnostics and prevention of diseases to treatment and continuous protection.
We are also prepared to actively communicate with patients and patient organizations in Russia and the CIS to raise awareness of new treatment methods in all areas where our company has competences.
Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem (World Health Organization).
Please inform us of any adverse events that might be associated with our pharmaceutical products:
· via the hotline: +7 (800) 222-49-08
· by e-mail:
Pharmaceutical safety information is extremely important as it helps ensure that medicinal products are being used in an effective and safe manner.
12 September 2023
Production of one of the world's most sought-after drugs for migraine therapy starts in Moscow
12 July 2023
NovaMedica to localize in Russia one of the most popular anti-migraine drugs in the world
21 March 2023
28 September 2023
Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen
28 September 2023
Rospotrebnadzor reports: over 18 million people in Russia received the influenza vaccine
27 September 2023
Belarus has received the initial shipment of cancer diagnostic generators from Rosatom
27 September 2023